CME Group: Strong Fundamentals Keep Fair Value Just Out of Reach
By stockpickr AI | March 1, 2026 | 10 min read
Investment Summary
CME Group, a dominant force in global derivatives markets, appears slightly overvalued based on the DCF analysis compared to its current market price, though strong fundamentals support the valuation.
Investment Recommendation
Hold
Fair Value: $191.50
Current Price: $187.08
Upside/Downside: +2.36%
The DCF analysis suggests an implied fair value per share near the current market price of $187.08, indicating the stock is currently fairly valued. The primary driver for the valuation is projected modest revenue growth maintained through strong market positioning.
Key Metrics
- Market Cap: $77.18B
- P/E Ratio: 20.52x
- Forward P/E: 19.15x
- Revenue Growth (YoY): 11.0%
- Net Margin: 33.9%
- ROE: 29.3%
- Debt/Equity: 3.05
- Dividend Yield: 2.95%
Strengths
- Dominant market share in global derivatives exchanges.
- Strong revenue resilience fueled by market interest rate volatility and high trading volumes.
- High profitability demonstrated by a 33.9% net margin in the last fiscal year.
- Consistent dividend growth supported by strong free cash flow generation.
Risk Factors
- High leverage relative to equity (Debt/Equity of 3.05).
- Potential for reduced trading volumes during periods of sustained low market volatility.
- Regulatory scrutiny surrounding derivatives trading and clearing functions.